Skip to Content

Clinical Trials Details

CTSU E1311

Patient Information

CTSU E1311 – A randomized, Placebo Controlled Phase II trial of Afatinib (BIBW2992) as Adjuvant Therapy following Chemoradiation in patients with Head and Neck squamous cell carcinoma at High risk of recurrence.

View more information about clinical trial - CTSU E1311

Study Number
CTSU E1311

Clinical Trial Categories

  • Head and Neck Cancer


  • Cone Health Cancer Center at Wesley Long
    501 N. Elam Avenue
    Greensboro, NC 27403
    Main: 336-832-1100

Also in this Section